CBU
LFST icon

CIBC Bancorp USA’s Lifestance Health LFST Stock Holding History

CIBC Bancorp USA’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$77.7K Buy
+14,125
New +$69.2K ﹤0.01% 1380

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CIBC Bancorp USA's LFST Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Lifestance Health (LFST) in Q3 2025: 14,125 shares worth $77.7K. The stake represents ﹤0.01% of the portfolio and ranks #1380 among its holdings.

210 funds tracked by Wall St. Rank hold LFST as of Q3 2025.

  • CIBC Bancorp USA held 14,125 shares of Lifestance Health worth $77.7K as of Q3 2025.
  • Lifestance Health was a new CIBC Bancorp USA position in Q3 2025.
  • Lifestance Health made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1380 holding.
  • 210 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.